Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novavax cites positive swine flu vaccine data
Yahoo/AP
Wednesday, March 24, 2010 - 9:50am
tags:
swine flu, vaccines, H1N1, Novava
Sequenom Story Still Unfolding
Seeking Alpha
Wednesday, March 24, 2010 - 9:49am
tags:
Sequenom
Struggling Poniard lays off more workers as it ponders options
Fierce Biotech
Wednesday, March 24, 2010 - 9:47am
tags:
Poniard, layoffs
Sanofi's $1B Multaq Heart-Drug Mess Is Getting Worse -- Quickly
BNET Pharma
Wednesday, March 24, 2010 - 9:46am
tags:
Multaq, Sanofi
Genzyme To Receive Consent Decree From The FDA
Pharmalot
Wednesday, March 24, 2010 - 9:45am
tags:
consent decree, Genzyme, FDA
Regeneron shares jump after CEO touts drugs
Reuters
Wednesday, March 24, 2010 - 9:45am
tags:
Regeneron, Aflibercept
No Patent! No Generics? Take Advantage of the Situation
Motley Fool
Wednesday, March 24, 2010 - 9:43am
tags:
generics, patents, Amgen, JNJ
Pfizer Defends Epilepsy Drug Neurontin at Fraud Trial
Bloomberg
Wednesday, March 24, 2010 - 7:41am
tags:
epilepsy, Pfizer, Neurontin, off-label
GlaxoSmithKline Criticized Over Avandia Tests by JAMA
CNBC
Wednesday, March 24, 2010 - 7:01am
tags:
Avandia, GSK, Journal of the American Medical Association.
Drugs: Fresh offensive combines several components
FT.com
Wednesday, March 24, 2010 - 6:59am
tags:
drug development, R&D, tuberculosis
Dynavax touts safety of hepatitis vaccine
Bizjournals.com
Wednesday, March 24, 2010 - 6:58am
tags:
Dynavax, vaccines, Heplisav, hepatitis B
Is There a Market for Biogen Idec?
Minyanville
Wednesday, March 24, 2010 - 6:57am
tags:
Biogen Idec, Carl Icahn
Merck, Pfizer 'Wins' From Healthcare Reform Could Be Elusive
Seeking Alpha
Tuesday, March 23, 2010 - 1:04pm
tags:
Merck, Pfizer, healthcare bill, healthcare reform
Former Johnson & Johnson manager sentenced for fraud
Mycentraljersey.com
Tuesday, March 23, 2010 - 12:00pm
tags:
JNJ, fraud
Alnylam nets another $20m from Takeda
Bizjournals.com
Tuesday, March 23, 2010 - 11:53am
tags:
Alnylam, Takeda, RNA interference
Simcere's Cancer Drug Makes Significant Headway in Trials
Seeking Alpha
Tuesday, March 23, 2010 - 11:36am
tags:
Simcere, Endostar
Somaxon share offering to fund insomnia drug plan
Yahoo/AP
Tuesday, March 23, 2010 - 11:35am
tags:
insomnia, Somaxon, Silenor, FDA
Greater research costs boots Inhibitex 4Q loss
Yahoo/AP
Tuesday, March 23, 2010 - 11:33am
tags:
Inhibitex, earnings
Surprise FDA Approvals of Rejected Drugs Are No Sign of Mercy
BNET Pharma
Tuesday, March 23, 2010 - 11:19am
tags:
FDA, Silenor, Somaxon
Merck KGaA halts cancer vaccine trial
Yahoo/AP
Tuesday, March 23, 2010 - 11:12am
tags:
Merck KGaA, vaccines, cancer, Stimuvax

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.